The Pavia consensus statement

AIDS

Volumn 17, Issue SUPPL. 1, 2003, Pages

  Volberding, Paul A ^a   Murphy, Robert L ^b   Barbaro, Giuseppe ^c,k   Barbarini, Giorgio ^d   Bruno, Raffaele ^d   Cirelli, Augusto ^c   Currie, Peter F ^e   Di Lorenzo, Gabriella ^c   Fantoni, Massimo ^f   Filice, Gaetano ^d   Galli, Massimo ^g   Grisorio, Benvenuto ^h   Moroni, Mauro ^g   Recusani, Franco ^d   Sacchi, Paolo ^d   Scevola, Daniele ^d   Stein, James H ^k   Torre, Donato ⁱ   Vittecoq, Daniel ^j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e PERTH ROYAL INFIRMARY   (United Kingdom)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h GENERAL HOSPITAL   (Italy)

ⁱ OSPEDALE DI CIRCOLO   (Italy)

^j HÔPITAL PAUL BROUSSE   (France)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMPRENAVIR; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIRETROVIRUS AGENT; BEPRIDIL; BIOCHEMICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLECAINIDE; FLUINDOSTATIN; GEMFIBROZIL; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDINAVIR; LOPINAVIR; MEVINOLIN; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PRAVASTATIN; PROPAFENONE; PROTEINASE INHIBITOR; QUINIDINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; SIMVASTATIN; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; ANAMNESIS; BLEEDING; BLOOD PRESSURE MONITORING; CARBOHYDRATE METABOLISM; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL CHEMISTRY; CONGESTIVE HEART FAILURE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ENDOTHELIUM; EXERCISE; GASTROINTESTINAL DISEASE; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERLIPIDEMIA; HYPERTENSION; INFECTION; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; MYOCARDITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANIZATION; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SMOKING; SURVIVAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; VERTIGO;

EID: 0038542987     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200304001-00021     Document Type: Review

References (1)

1. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-97.